Chuba P J, Aronin P, Bhambhani K, Eichenhorn M, Zamarano L, Cianci P, Muhlbauer M, Porter A T, Fontanesi J
Department of Radiation Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 48236, USA.
Cancer. 1997 Nov 15;80(10):2005-12. doi: 10.1002/(sici)1097-0142(19971115)80:10<2005::aid-cncr19>3.0.co;2-0.
Radiation-induced necrosis (RIN) of the brain is a complication associated with the use of aggressive focal treatments such as radioactive implants and stereotactic radiosurgery. In an attempt to treat patients with central nervous system (CNS) RIN, ten patients received hyperbaric oxygen treatment (HBOT).
Patients presented with new or increasing neurologic deficits associated with imaging changes after radiotherapy. Necrosis was proven by biopsy in eight cases. HBOT was comprised of 20-30 sessions at 2.0 to 2.4 atmospheres, for 90 minutes-2 hours. Sites of RIN included the brain stem (n = 2), posterior fossa (n = 1), and supratentorial fossa (n 7). Histologic types included brain stem glioma (n = 2), ependymoma (n = 2), germinoma (n = 2), low grade astrocytoma (n = 1), oligodendroglioma (n = 1), glioblastoma multiforme (n = 1), and arteriovenous malformation (n = 1).
Initial improvement or stabilization of symptoms and/or imaging findings were documented in all ten patients studied and no severe HBOT toxicity was observed. Four patients died, with the cause of death attributed to tumor progression. Five of six surviving patients were improved by clinical and imaging criteria; one patient was alive with tumor present at last follow-up.
HBOT may prove to be an important adjunct to surgery and steroid therapy for CNS RIN.
脑放射性坏死(RIN)是一种与使用放射性植入物和立体定向放射外科等积极的局部治疗相关的并发症。为了治疗中枢神经系统(CNS)RIN患者,10名患者接受了高压氧治疗(HBOT)。
患者在放疗后出现与影像学改变相关的新的或加重的神经功能缺损。8例经活检证实为坏死。HBOT包括在2.0至2.4个大气压下进行20 - 30次治疗,每次90分钟至2小时。RIN的部位包括脑干(n = 2)、后颅窝(n = 1)和幕上窝(n = 7)。组织学类型包括脑干胶质瘤(n = 2)、室管膜瘤(n = 2)、生殖细胞瘤(n = 2)、低级别星形细胞瘤(n = 1)、少突胶质细胞瘤(n = 1)、多形性胶质母细胞瘤(n = 1)和动静脉畸形(n = 1)。
在所有10例研究患者中均记录到症状和/或影像学表现的初始改善或稳定,且未观察到严重的HBOT毒性。4例患者死亡,死亡原因归因于肿瘤进展。6例存活患者中有5例在临床和影像学标准上有所改善;1例患者在最后一次随访时仍存活且有肿瘤。
对于CNS RIN,HBOT可能被证明是手术和类固醇治疗的重要辅助手段。